Product Information
NAPROXEN 125 MG/5 ML SUSPEN is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.1912 per ML under NDC 70954015110. Its NADAC has been published 127 times since Mar 20, 2024.
FDA first approved this application on Mar 10, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
125 mg/5mL
Manufacturer
ANI Pharmaceuticals, Inc.NDC
70954015110
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
NAPROXENApproval Type
Generic (ANDA)
FDA Application
ANDA211910FDA Approved
3/10/2021
TE Code
AB
On Market Since
3/12/2021
Pharmacological Classes
Price Statistics
The NADAC for NAPROXEN 125 MG/5 ML SUSPEN has been published 127 times since Mar 20, 2024, and over the history we have for it it has declined 79.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1912 per ML |
|---|---|
| All-time high | $0.9187 (Apr 10, 2024) |
| All-time low | $0.1654 (Mar 18, 2026) |
| 52-week high | $0.2346 |
| 52-week low | $0.1654 |
| Median price | $0.3038 |
| Average price | $0.3608 |
| Largest weekly change | -33.2% (Oct 23, 2024) |
| Weeks tracked | 127 |
| Tracking since | Mar 20, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Naproxen oral market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of NAPROXEN 125 MG/5 ML SUSPEN?
The current National Average Drug Acquisition Cost (NADAC) for NAPROXEN 125 MG/5 ML SUSPEN, manufactured by ANI Pharmaceuticals, Inc., is $0.1912 per ML (NDC 70954015110), effective Aug 19, 2026.
How has the price of NAPROXEN 125 MG/5 ML SUSPEN changed over time?
Over the history we have for it, the NADAC for NAPROXEN 125 MG/5 ML SUSPEN has declined 79.2%. It has been tracked across 127 weekly CMS publications since Mar 20, 2024.
What are the highest and lowest recorded NADAC prices for NAPROXEN 125 MG/5 ML SUSPEN?
Since Mar 20, 2024, the NADAC for NAPROXEN 125 MG/5 ML SUSPEN has ranged from a low of $0.1654 (Mar 18, 2026) to a high of $0.9187 (Apr 10, 2024), with a median of $0.3038 per ML.
Are there cheaper alternatives to NAPROXEN 125 MG/5 ML SUSPEN?
No other NADAC-published product currently shares the active ingredient and strength of NAPROXEN 125 MG/5 ML SUSPEN in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures NAPROXEN 125 MG/5 ML SUSPEN?
NAPROXEN 125 MG/5 ML SUSPEN (NDC 70954015110) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.